| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 42 |
| 1 | OMEPRAZOLE | 35 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 20 |
| 3 | FUROSEMIDE | 20 |
| 4 | ACETAMINOPHEN | 15 |
| 5 | ADALIMUMAB | 15 |
| 6 | IBUPROFEN | 15 |
| 7 | METHOTREXATE SODIUM | 15 |
| 8 | ASPIRIN | 14 |
| 9 | ASPIRIN 325 MG | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | 1 | 0.0027 |
| 1 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 2 | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | 1 | 0.0015 |
| 3 | LANTHANUM CARBONATE | 6 | 0.0012 |
| 4 | VONOPRAZAN FUMARATE | 9 | 0.0011 |
| 5 | COLESEVELAM HYDROCHLORIDE | 1 | 0.0009 |
| 6 | PSYLLIUM HUSK | 1 | 0.0007 |
| 7 | POTASSIUM ACETATE | 1 | 0.0007 |
| 8 | CALCIUM POLYCARBOPHIL | 2 | 0.0007 |
| 9 | ZOLBETUXIMAB | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 51 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 39 |
| 2 | Loop Diuretic [EPC] | 21 |
| 3 | Corticosteroid [EPC] | 19 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 12 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| 8 | Vitamin C [EPC] | 11 |
| 9 | Benzodiazepine [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 1 | GLP-2 Analog [EPC] | 8 | 0.0006 |
| 2 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 6 | Cannabinoid [EPC] | 1 | 0.0001 |
| 7 | Antimalarial [EPC] | 1 | 0.0001 |
| 8 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 9 | Proton Pump Inhibitor [EPC] | 51 | 0.0001 |